Cargando…

Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients

BACKGROUND: ALCAM (activated leukocyte cell adhesion molecule, CD166, MEMD) is a transmembrane protein of immunoglobulin superfamily (Ig-SF) and plays an important role in human malignant melanoma progression and formation of locoregional and distant metastases. The study using melanoma cell lines s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Donizy, Piotr, Zietek, Marcin, Halon, Agnieszka, Leskiewicz, Marek, Kozyra, Cyprian, Matkowski, Rafal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489046/ https://www.ncbi.nlm.nih.gov/pubmed/26134500 http://dx.doi.org/10.1186/s13000-015-0331-z

Ejemplares similares

High Percentage of ADAM-10 Positive Melanoma Cells Correlates with Paucity of Tumor-Infiltrating Lymphocytes but Does Not Predict Prognosis in Cutaneous Melanoma Patients
por: Donizy, Piotr, et al.
Publicado: (2015)

Augmented expression of Polo-like kinase 1 is a strong predictor of shorter cancer-specific overall survival in early stage breast cancer at 15-year follow-up
por: Donizy, Piotr, et al.
Publicado: (2016)

Nucleoli cytomorphology in cutaneous melanoma cells – a new prognostic approach to an old concept
por: Donizy, Piotr, et al.
Publicado: (2017)

Golgi-Related Proteins GOLPH2 (GP73/GOLM1) and GOLPH3 (GOPP1/MIDAS) in Cutaneous Melanoma: Patterns of Expression and Prognostic Significance
por: Donizy, Piotr, et al.
Publicado: (2016)

Upregulation of FOXP1 is a new independent unfavorable prognosticator and a specific predictor of lymphatic dissemination in cutaneous melanoma patients
por: Donizy, Piotr, et al.
Publicado: (2018)

ALCAM (CD166) Expression and Serum Levels in Pancreatic Cancer
por: Tachezy, Michael, et al.
Publicado: (2012)

ERM/Rho protein expression in ductal breast cancer: a 15 year follow-up
por: Halon, Agnieszka, et al.
Publicado: (2013)

HER-2 Expression in Immunohistochemistry Has No Prognostic Significance in Gastric Cancer Patients
por: Halon, Agnieszka, et al.
Publicado: (2012)

Enhanced down-regulation of ALCAM/CD166 in African-American Breast Cancer
por: Tan, Fang, et al.
Publicado: (2014)

ALCAM/CD166 Is Involved in the Binding and Uptake of Cancer-Derived Extracellular Vesicles
por: Cardeñes, Beatriz, et al.
Publicado: (2022)

Combinations of EGFR and MET inhibitors reduce proliferation and invasiveness of mucosal melanoma cells
por: Simiczyjew, Aleksandra, et al.
Publicado: (2023)

Biological Aggressiveness of Subclinical No-Mass Ductal Carcinoma In Situ (DCIS) Can Be Reflected by the Expression Profiles of Epithelial-Mesenchymal Transition Triggers
por: Szynglarewicz, Bartlomiej, et al.
Publicado: (2018)

ANGI-03 Functional roles of CD166/activated leukocyte cell adhesion molecule (CD166/ALCAM) for glioblastoma invasion
por: Kijima, Noriyuki, et al.
Publicado: (2020)

Correlation Between PARP-1 Immunoreactivity and Cytomorphological Features of Parthanatos, a Specific Cellular Death in Breast Cancer Cells
por: Donizy, P., et al.
Publicado: (2013)

CD166/ALCAM Expression Is Characteristic of Tumorigenicity and Invasive and Migratory Activities of Pancreatic Cancer Cells
por: Fujiwara, Kenji, et al.
Publicado: (2014)

Activated leukocyte cell adhesion molecule (ALCAM or CD166) modulates bone phenotype and hematopoiesis
por: Hooker, R.A., et al.
Publicado: (2015)

ALCAM (CD166) as a gene expression marker for human mesenchymal stromal cell characterisation
por: Brinkhof, Bas, et al.
Publicado: (2020)

MRP2 (ABCC2, cMOAT) expression in nuclear envelope of primary fallopian tube cancer cells is a new unfavorable prognostic factor
por: Halon, Agnieszka, et al.
Publicado: (2012)

The Clinical and Theranostic Values of Activated Leukocyte Cell Adhesion Molecule (ALCAM)/CD166 in Human Solid Cancers
por: Yang, Yiming, et al.
Publicado: (2021)

Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse
por: Kahlert, C, et al.
Publicado: (2009)

Cell Adhesion Molecule CD166/ALCAM Functions Within the Crypt to Orchestrate Murine Intestinal Stem Cell Homeostasis
por: Smith, Nicholas R., et al.
Publicado: (2017)

The Influence of Tumor Microenvironment on Immune Escape of Melanoma
por: Simiczyjew, Aleksandra, et al.
Publicado: (2020)

Expression Levels of Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166) in Primary Breast Carcinoma and Distant Breast Cancer Metastases
por: Ihnen, M., et al.
Publicado: (2010)

Tissue laser biostimulation promotes post-extraction neoangiogenesis in HIV-infected patients
por: Halon, Agnieszka, et al.
Publicado: (2013)

Preoperatively diagnosed ductal cancers in situ of the breast presenting as even small masses are of high risk for the invasive cancer foci in postoperative specimen
por: Szynglarewicz, Bartlomiej, et al.
Publicado: (2015)

Lobular carcinoma in situ of the breast – correlation between minimally invasive biopsy and final pathology
por: Szynglarewicz, Bartłomiej, et al.
Publicado: (2016)

Hypoxia and Extracellular Acidification as Drivers of Melanoma Progression and Drug Resistance
por: Dratkiewicz, Ewelina, et al.
Publicado: (2021)

Cancer stem cells – the current status of an old concept: literature review and clinical approaches
por: Fulawka, Lukasz, et al.
Publicado: (2014)

Introduction of a pilot program to measure and improve the clinical care of melanoma patients in the Lower Silesian Voivodeship in Poland: a report of 20 months experience
por: Ziętek, Marcin, et al.
Publicado: (2022)

Stromal Cells Present in the Melanoma Niche Affect Tumor Invasiveness and Its Resistance to Therapy
por: Mazurkiewicz, Justyna, et al.
Publicado: (2021)

Prognostic Significance of Activated Leukocyte Cell Adhesion Molecule (ALCAM) in Association with Promoter Methylation of the ALCAM Gene in Breast Cancer
por: Jeong, Young Ju, et al.
Publicado: (2018)

A novel human recombinant single-chain antibody targeting CD166/ALCAM inhibits cancer cell invasion in vitro and in vivo tumour growth
por: Wiiger, Merete Thune, et al.
Publicado: (2010)

The effect of YAP expression in tumor cells and tumor stroma on the prognosis of patients with squamous cell carcinoma of the oral cavity floor and oral surface of the tongue
por: Szelachowska, Jolanta, et al.
Publicado: (2019)

Screen-detected ductal carcinoma in situ found on stereotactic vacuum-assisted biopsy of suspicious microcalcifications without mass: radiological-histological correlation
por: Szynglarewicz, Bartlomiej, et al.
Publicado: (2016)

An analysis of clinical effectiveness of electrochemotherapy in the treatment of advanced metastatic malignant melanoma performed in the eastern part of Central Europe: a single-centre experience
por: Ziętek, Marcin, et al.
Publicado: (2022)

Outcomes of Patients with Metastatic Melanoma—A Single-Institution Retrospective Analysis
por: Szatkowska, Lidia, et al.
Publicado: (2022)

Incidence of different types of cancer in the follow-up period after primary diagnosis and treatment of melanoma. Single-centre 4-year follow-up on a population of 709 patients
por: Ziętek, Marcin, et al.
Publicado: (2023)

Combination of Selected MET and EGFR Inhibitors Decreases Melanoma Cells’ Invasive Abilities
por: Simiczyjew, Aleksandra, et al.
Publicado: (2019)

Melanoma cells induce dedifferentiation and metabolic changes in adipocytes present in the tumor niche
por: Simiczyjew, Aleksandra, et al.
Publicado: (2023)

Severe complications of nivolumab monotherapy in an adolescent with malignant melanoma
por: Grzegorczyk, Aleksandra, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4dlshuskcp7om84unb5i41c51a